GLIDR-mediated regulation of tumor malignancy and cisplatin resistance in non-small cell lung cancer via the miR-342-5p/PPARGC1A axis

Ruihua Liu,Jiemin Wang,Lichun Zhang,Shu Wang,Xiangnan Li,Yueshi Liu,Haiquan Yu
DOI: https://doi.org/10.1186/s12885-024-12845-y
IF: 4.638
2024-09-11
BMC Cancer
Abstract:Lung cancer, particularly non-small cell lung cancer (NSCLC), remains a significant cause of cancer-related mortality, with drug resistance posing a substantial obstacle to effective therapy. LncRNAs have emerged as pivotal regulators of NSCLC progression, suggesting potential targets for cancer diagnosis and treatment. Therefore, identifying new lncRNAs as therapeutic targets and comprehending their underlying regulatory mechanisms are crucial for treating NSCLC.
oncology
What problem does this paper attempt to address?